These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24648158

  • 41. Highly loaded, sustained-release microparticles of curcumin for chemoprevention.
    Shahani K, Panyam J.
    J Pharm Sci; 2011 Jul; 100(7):2599-609. PubMed ID: 21547911
    [Abstract] [Full Text] [Related]

  • 42. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
    Yoncheva K, Lambov N, Miloshev S.
    Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
    [Abstract] [Full Text] [Related]

  • 43. Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process.
    Kempe S, Metz H, Mäder K.
    J Control Release; 2008 Sep 24; 130(3):220-5. PubMed ID: 18611421
    [Abstract] [Full Text] [Related]

  • 44. Investigation of Fragment Antibody Stability and Its Release Mechanism from Poly(Lactide-co-Glycolide)-Triacetin Depots for Sustained-Release Applications.
    Chang DP, Garripelli VK, Rea J, Kelley R, Rajagopal K.
    J Pharm Sci; 2015 Oct 24; 104(10):3404-17. PubMed ID: 26099467
    [Abstract] [Full Text] [Related]

  • 45. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR, Elkharraz K, Irfan M, Bodmeier R.
    Pharm Dev Technol; 2012 Oct 24; 17(1):66-72. PubMed ID: 20854130
    [Abstract] [Full Text] [Related]

  • 46. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L.
    J Control Release; 2010 Jan 25; 141(2):153-60. PubMed ID: 19772878
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M, Prabhakaran MP, Varshosaz J, Mhaisalkar PS, Ramakrishna S.
    Acta Biomater; 2016 Sep 15; 42():316-328. PubMed ID: 27397493
    [Abstract] [Full Text] [Related]

  • 49. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
    Luan X, Bodmeier R.
    Eur J Pharm Sci; 2006 Feb 15; 27(2-3):143-9. PubMed ID: 16243496
    [Abstract] [Full Text] [Related]

  • 50. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
    Shen J, Burgess DJ.
    Int J Pharm; 2012 Jan 17; 422(1-2):341-8. PubMed ID: 22016033
    [Abstract] [Full Text] [Related]

  • 51. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
    Liang R, Zhang R, Li X, Wang A, Chen D, Sun K, Liu W, Li Y.
    Eur J Pharm Sci; 2013 Nov 20; 50(3-4):502-10. PubMed ID: 23994054
    [Abstract] [Full Text] [Related]

  • 52. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X, Xu Y, Chen G, Wei P, Ping Q.
    Drug Dev Ind Pharm; 2008 Jan 20; 34(1):107-15. PubMed ID: 18214762
    [Abstract] [Full Text] [Related]

  • 53. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH, Park TG.
    Int J Pharm; 2006 Mar 27; 311(1-2):223-8. PubMed ID: 16423477
    [Abstract] [Full Text] [Related]

  • 54. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y, Sturek M, Park K.
    Int J Pharm; 2014 Jan 30; 461(1-2):258-69. PubMed ID: 24333903
    [Abstract] [Full Text] [Related]

  • 55. Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant.
    Yu Y, Ngo HV, Jin G, Tran PHL, Tran TTD, Nguyen VH, Park C, Lee BJ.
    Int J Nanomedicine; 2021 Jan 30; 16():2819-2831. PubMed ID: 33888982
    [Abstract] [Full Text] [Related]

  • 56. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.
    Liu Q, Zhang H, Zhou G, Xie S, Zou H, Yu Y, Li G, Sun D, Zhang G, Lu Y, Zhong Y.
    Int J Pharm; 2010 Sep 15; 397(1-2):122-9. PubMed ID: 20650309
    [Abstract] [Full Text] [Related]

  • 57. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
    Ramchandani M, Robinson D.
    J Control Release; 1998 Jul 31; 54(2):167-75. PubMed ID: 9724903
    [Abstract] [Full Text] [Related]

  • 58. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG, Olsen KF, Mallery SR, Stoner GD, Schwendeman SP.
    Pharm Res; 2010 Apr 31; 27(4):628-43. PubMed ID: 20148292
    [Abstract] [Full Text] [Related]

  • 59. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.
    Mukherjee B, Santra K, Pattnaik G, Ghosh S.
    Int J Nanomedicine; 2008 Apr 31; 3(4):487-96. PubMed ID: 19337417
    [Abstract] [Full Text] [Related]

  • 60. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y, Wu J, Yin G, Huang Z, Yao Y, Liao X, Chen A, Pu X, Liao L.
    Eur J Pharm Biopharm; 2008 Sep 31; 70(1):85-97. PubMed ID: 18495445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.